Progesterone for Postpartum Cocaine Relapse

Completed · Not applicable · Has a placebo group

Conditions studied: Cocaine Abuse, Cocaine Dependence

In brief

The investigators propose a placebo-controlled, randomized clinical trial that would enroll 50 postpartum women with a history of cocaine abuse or dependence to assess whether progesterone (100mgs twice daily) decreases postpartum cocaine use.

Key facts

Study ID

NCT01249274

Run by

Yale University

People needed

50

Starts

2011-02-01

Expected to finish

2013-07-01

Last updated by the study team

2017-03-28

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Gravidas (women who delivered a baby in the past 12 weeks) who are 18 or older are eligible to participate.
• Women must meet diagnostic criteria for abuse or dependence of cocaine in the six-months prior to conception or during pregnancy.
• Women who abuse other illicit substances or alcohol would also be eligible as long as cocaine was their primary drug of abuse. If women are also opiate dependent, they must be undergoing treatment with methadone or buprenorphine. While we propose to target cocaine we will also monitor the ability of women with polysubstance use to maintain abstinence from substances other than cocaine.

You may not qualify if…

• Women will be ineligible for the trial if they:
• have a history of major medical illnesses including liver diseases, suspected or known malignancy, thrombophlebitis, deep vein thrombosis, pulmonary embolus, clotting or bleeding disorders, heart disease, diabetes, history of stroke or other medical conditions that the physician investigator deems as contraindicated for participation in the study;
• have a known allergy to progesterone or peanuts (vehicle for micronized progesterone);
• speak a language other than English;
• are planning on moving out of the area in the first six months after delivery;
• are unable to understand the study or are unable to provide informed consent;
• are currently undergoing treatment with another pharmacological agent for substance abuse treatment (with the exception of methadone or buprenorphine as above);
• have pending incarceration;
• are currently incarcerated;
• are using another progestin;
• are unwilling to accept randomization;
• are unwilling to use a barrier method of birth control for the duration of the study to ensure that they will not become pregnant.

Where it is running

• Yale School of Medicine — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.